Give research topics about pulmonary risk stratification in predicting PPCs

Reading File
Finding Sources
Searching PubMed

"postoperative pulmonary complications" AND "risk stratification"

Searching the Web

pulmonary risk stratification predicting postoperative pulmonary complications research topics 2024 2025

Finding Sources
Searching PubMed

"postoperative pulmonary complications" AND "prediction" AND "scoring"

Reading File
Reading File
Searching PubMed

"postoperative pulmonary complications" AND ("machine learning" OR "artificial intelligence" OR "deep learning")

Here is a well-organized set of research topics on pulmonary risk stratification in predicting postoperative pulmonary complications (PPCs), drawn from current evidence and active research frontiers:

Research Topics: Pulmonary Risk Stratification in Predicting PPCs


1. Validation and Comparison of Existing Risk Scoring Tools

Focus: Head-to-head comparison of established risk indices across different surgical populations and geographic settings.
  • ARISCAT (Assess Respiratory Risk in Surgical Patients in Catalonia) - the most widely recommended multifactorial score (age, preoperative SpO2, recent respiratory infection, surgical site, operative duration, hemoglobin, emergency surgery). Its external validity varies across non-European populations, opening research gaps.
  • LAS VEGAS Score vs. ARISCAT in cardiac and thoracic surgery (Siddiqui et al., 2024, PMID 38989237)
  • NSQIP Pneumonia Risk Tool and NSQIP Respiratory Failure Risk Tool - derived from >180 U.S. hospitals, validated across large multicenter datasets
  • Gupta Respiratory Failure Calculator - procedure-specific regression model
  • Research question: Which score performs best across non-Western, elderly, obese, or immunocompromised surgical populations?

2. Systematic Review and Meta-Analysis of Prediction Models

Focus: Pooled performance of multivariable prediction models for PPCs.
  • A 2025 meta-analysis in the British Journal of Anaesthesia (Huang et al., PMID 40473567) found discriminative ability and clinical impact of PPC prediction models remains inconsistent - pointing to a major research opportunity.
  • Evaluation of model calibration, discrimination (AUROC), and clinical net benefit across studies.
  • The 2022 Lancet Digital Health study (PMID 35750401) externally validated multiple prognostic models for major abdominal surgery patients internationally.
  • Research question: What is the methodological quality (PROBAST criteria) of existing PPC prediction models, and how many are ready for clinical deployment?

3. Machine Learning and AI-Based Risk Prediction Models

Focus: Whether ML algorithms outperform traditional logistic regression for PPC prediction.
  • Explainable ML (SHAP analysis) applied to thoracoscopic surgery patients to identify the most important modifiable predictors (Wang et al., 2025, PMID 40688297)
  • Automated ML (AutoML) pipelines for non-small cell lung cancer (NSCLC) patients undergoing thoracoscopic surgery (Qiu et al., 2025, PMID 41004509)
  • Intraoperative respiratory dynamic features (real-time ventilator data streams) as ML model inputs (Li et al., 2024, PMID 38637267)
  • Deep neural network models in geriatric patients (multicenter prospective, PMID 36017511)
  • ML models after neurosurgery - a relatively understudied surgical subgroup (Xu et al., 2025, PMID 39947880)
  • Research question: Can real-time intraoperative AI models outperform preoperative scoring tools in predicting PPCs?

4. Pulmonary Function Testing (PFT) as a Stratification Tool

Focus: Whether spirometry and other PFTs add meaningful predictive value beyond clinical scores.
  • A 2022 systematic review (Dankert et al., PMID 34939921) found PFTs add limited incremental value for noncardiothoracic surgery, but remain indispensable before lung resection.
  • Key thresholds: FEV1 <2 L, MVV <50% predicted, PCO2 ≥45 mmHg, PO2 ≤50 mmHg (Harrison's Principles of Internal Medicine, 22e)
  • Research question: What PFT thresholds or composite indices optimally stratify risk for specific surgical subgroups (thoracic, upper abdominal, spine)?

5. New Prediction Models for Lung Resection Candidates

Focus: Specialized models beyond the traditional FEV1/DLCO framework.
  • Novel models incorporating cardiopulmonary exercise testing (CPET) variables, VO2 max, and ventilatory equivalents (Svoboda et al., 2024, ERJ Open Research, PMID 39286055)
  • Integration of predicted postoperative (ppo) lung function with functional capacity measures
  • Research question: What combination of preoperative assessments (spirometry + CPET + imaging) provides the most accurate PPC risk estimate for thoracic oncology patients?

6. Operative and Procedure-Specific Risk Stratification

Focus: Surgical site and operative technique as dominant risk modifiers.
  • High-risk procedures: aortic surgery, esophagectomy, thoracotomy, upper abdominal surgery - procedure-related risk outweighs patient-related risk (Murray & Nadel's Textbook of Respiratory Medicine)
  • Minimally invasive (VATS/RATS) vs. open thoracotomy - differential PPC rates and risk model applicability
  • Upper abdominal surgery (Garg et al., 2025, PMID 38526466) - spirometry and clinical predictors
  • Research question: Should procedure-specific PPC risk models replace universal scores for high-risk surgeries?

7. Patient-Specific Risk Factor Research

Focus: Identifying and quantifying the contribution of individual patient factors.
  • Obstructive Sleep Apnea (OSA): STOP-BANG screening and its predictive role for PPCs and postoperative desaturation
  • Frailty and functional dependence in elderly patients - frailty indices vs. ASA class
  • Obesity and BMI - controversial predictor; uncomplicated obesity may not substantially increase PPC risk (Fishman's Pulmonary Diseases)
  • Malnutrition (serum albumin <3.5 g/dL) as an independent risk factor
  • Preoperative anemia (Hb <10 g/dL) - included in ARISCAT
  • Research question: How does multimorbidity clustering (e.g., COPD + OSA + low albumin) compound PPC risk beyond individual factor scoring?

8. Lung Ultrasound as a Perioperative Risk Stratification Tool

Focus: Whether point-of-care lung ultrasound (LUS) scores add predictive power.
  • Lung Ultrasound Score (LUS) for predicting PPCs - an emerging and debated topic (Vetrugno et al., 2026, European Journal of Anaesthesiology, PMID 41340139)
  • Pre- and postoperative LUS for early detection of atelectasis, consolidation, and pleural effusion
  • Research question: What is the additive value of preoperative LUS over clinical risk scores in stratifying PPC risk?

9. Risk Stratification in Specific Patient Populations

Focus: Population-specific model development and validation.
  • Geriatric patients: Deep neural network models (PMID 36017511); ASA class and functional dependence are stronger predictors than comorbidities alone
  • Lung cancer surgery patients: Explainable ML incorporating tumor characteristics and staging (Chen et al., 2025, PMID 40791887)
  • Cardiac surgery patients: Nomograms post-CABG (Khanna et al., 2023, PMID 34689983)
  • Neurosurgery patients: Multicenter ML model development (PMID 39947880)
  • Urological surgery: ARISCAT validation in major urological procedures (PMID 40948164)
  • Esophageal cancer surgery: Unique PPC profile given one-lung ventilation and thoracoabdominal access (Duff et al., 2022, PMID 35393612)
  • Research question: Are universal PPC scoring tools valid in surgical subspecialties, or should population-specific models be developed and mandated?

10. Intraoperative Risk Modification and Its Interaction with Preoperative Stratification

Focus: Whether optimizing intraoperative management changes the predictive value of preoperative scores.
  • Lung-protective ventilation (LPV): Low tidal volume + PEEP titration - meta-analysis showing PEEP 5 cmH2O + plateau pressure ≤16 cmH2O reduces PPC risk (Miller's Anesthesia 10e)
  • Driving pressure-guided ventilation - 2024 meta-analysis (PMID 38937217) supports it as a modifier of PPC risk
  • Neuromuscular blockade reversal with sugammadex vs. neostigmine - meta-analysis showing superiority of sugammadex in PPC prevention (PMID 37027443)
  • Neuraxial vs. general anesthesia - epidural and spinal techniques reduce PPCs in abdominal surgery
  • Research question: Do preoperative risk scores retain their discriminative ability when patients receive standardized lung-protective intraoperative protocols?

11. Standardization of PPC Definitions and Outcome Measurement

Focus: Methodological and definitional inconsistency as a barrier to research synthesis.
  • The StEP-COMPAC (Standardized Endpoints in Perioperative Medicine) and EPCO (European Perioperative Clinical Outcome) definitions as reference frameworks
  • Heterogeneity in composite PPC endpoints vs. individual outcome reporting (pneumonia, atelectasis, ARDS, respiratory failure, PE, pneumothorax, reintubation)
  • Research question: How do different PPC outcome definitions affect the apparent performance of risk stratification tools?

12. Preoperative Optimization Strategies Guided by Risk Stratification

Focus: Translating risk scores into targeted interventions.
  • Inspiratory muscle training (IMT) in high-risk patients pre-surgery
  • Prehabilitation programs combining exercise, nutrition, and smoking cessation
  • Oral hygiene protocols and decolonization to reduce postoperative pneumonia
  • Research question: Does individualized preoperative optimization based on PPC risk stratification reduce actual complication rates vs. standard care?

Summary Table of Key Research Areas

#Topic AreaKey Tools/MethodsEvidence Gap
1Risk score comparisonARISCAT, LAS VEGAS, NSQIPGeographic/population validation
2Systematic reviews of prediction modelsPROBAST, meta-analysisModel quality and deployment readiness
3AI/ML predictionXGBoost, SHAP, AutoMLProspective implementation trials
4Pulmonary function testingSpirometry, DLCOIncremental value in non-thoracic surgery
5Lung resection modelsCPET, ppoFEV1Novel composite models
6Procedure-specific riskSurgical site stratificationSubspecialty-specific model development
7Patient-specific factorsOSA, frailty, malnutritionMultimorbidity interaction modeling
8Lung ultrasound scoringLUS perioperativeAdded value over clinical scores
9Special populationsGeriatric, oncologic, cardiacExternal validation in diverse groups
10Intraoperative modificationLPV, PEEP, sugammadexInteraction with preoperative score performance
11PPC outcome standardizationStEP-COMPAC, EPCOConsensus endpoint adoption
12Preoperative optimizationPrehabilitation, IMTRCTs linking risk score to intervention benefit

Key Recent References to Anchor a Literature Review:
  • Huang et al. (2025) - Prediction models for PPCs: systematic review & meta-analysis. Br J Anaesth [PMID 40473567]
  • LePledge et al. / Lancet Digital Health (2022) - External validation of prognostic models for abdominal surgery [PMID 35750401]
  • Li et al. (2024) - Intraoperative respiratory dynamics + explainable ML [PMID 38637267]
  • Dankert et al. (2022) - PFTs for PPC prediction: systematic review [PMID 34939921]
  • Gu et al. (2024) - Driving pressure-guided ventilation meta-analysis [PMID 38937217]

preop tests to use for predicting PPCs aside from CPET

Finding Sources
Searching PubMed

"postoperative pulmonary complications" AND "preoperative testing" AND "prediction"

Searching the Web

preoperative tests predicting postoperative pulmonary complications spirometry PFT chest xray blood gas 2024 2025

Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Here is a comprehensive breakdown of preoperative tests used to predict PPCs (excluding CPET), with evidence-based guidance on which to use, when, and their limitations:

Preoperative Tests for Predicting PPCs (Excluding CPET)


1. Pulse Oximetry (SpO2)

What it measures: Resting oxygen saturation on room air, in the supine position.
Role in PPC prediction: This is one of the strongest and most practical predictors of PPCs. It is a core component of the ARISCAT score - one of the most validated PPC risk tools available.
Preoperative SpO2ARISCAT Risk PointsOdds Ratio for PPCs
≥96%0Reference
91-95%8OR 2.2 (95% CI 1.2-4.2)
≤90%24OR 10.7 (95% CI 4.1-28.1)
Recommendation: Obtain in ALL preoperative patients; it is non-invasive, inexpensive, and highly informative. Measure supine and on room air for accuracy.
(Murray & Nadel's Textbook of Respiratory Medicine; Fischer's Mastery of Surgery, 8e)

2. Spirometry / Pulmonary Function Tests (PFTs)

What it measures: FEV1, FVC, FEV1/FVC ratio, MVV, FEF25-75%, DLCO (diffusing capacity).
Role in PPC prediction:
  • Lung resection (thoracic surgery): Spirometry and DLCO are mandatory and well-validated. Key thresholds before resection:
    • FEV1 <2 L or <80% predicted - elevated risk
    • MVV <50% predicted
    • ppoFEV1 <40% - high risk for resection
    • DLCO <40% predicted - contraindication to pneumonectomy
  • Noncardiothoracic surgery: Spirometry adds limited incremental value beyond clinical history and physical exam. A 2022 systematic review (Dankert et al., PMID 34939921) concluded that evidence for PFTs in non-thoracic surgery remains weak, though subgroup analysis suggests benefit in upper abdominal surgery.
When spirometry IS indicated (Fischer's Mastery of Surgery 8e; Harrison's, 22e):
  • All patients undergoing lung resection
  • Suspected but undiagnosed COPD
  • Known COPD/asthma where baseline function cannot be assessed clinically
  • Patients with symptoms disproportionate to their known disease
When spirometry is NOT routinely recommended (Murray & Nadel; Harrison's 22e):
  • Asymptomatic patients
  • Cardiac surgery without new/worsened cardiopulmonary symptoms ("Choosing Wisely" recommendation)
  • General elective surgery without pulmonary comorbidities
Key caveat: Abnormal spirometry does correlate with PPCs but does not clearly provide additional risk prediction above a careful history and exam in most noncardiothoracic surgery patients.

3. Chest Radiograph (CXR)

Role in PPC prediction: CXR abnormalities are associated with PPCs, but routine screening CXRs in asymptomatic patients are not recommended (Maingot's Abdominal Operations; Fischer's Mastery of Surgery 8e).
Indications for preoperative CXR per ACP and ACC/AHA:
  • History of known cardiopulmonary disease
  • Age ≥50 undergoing upper abdominal, thoracic, or aortic surgery
  • Severe obesity (BMI >40 kg/m2) - to screen for undiagnosed CHF, pulmonary HTN, or cardiomegaly
  • Clinical suspicion of infection or bullous emphysema
  • Abnormal findings on physical exam
What to look for: Hyperinflation, consolidation, pleural effusion, cardiomegaly, pulmonary vascular congestion, atelectasis, masses.
Limitation: Low incremental predictive value in the absence of clinical abnormality; rarely changes management in already-assessed patients.

4. Arterial Blood Gas (ABG)

What it measures: PaO2, PaCO2, pH, bicarbonate, base excess.
Relevant thresholds:
  • PaO2 <60 mmHg on room air - increased PPC risk
  • PaCO2 ≥45 mmHg - associated with increased perioperative risk, especially for thoracic surgery (Cummings Otolaryngology; Maingot's Abdominal Operations)
  • Elevated serum HCO3- in patients with suspected OSA - suggests chronic CO2 retention and possible obesity hypoventilation syndrome (OHS), which substantially increases risk
Role in PPC prediction:
  • Lung resection: Provides useful baseline for patients with chronic CO2 retention.
  • Noncardiothoracic surgery: Limited value - hypercapnia is usually clinically apparent and ABG rarely alters management (Murray & Nadel's). A 2025 study (IJCMAAS) found ABG was a poor predictor in elective abdominal surgery (AUC 0.611, non-significant).
  • Suspected OSA: Elevated serum bicarbonate on routine labs is a reasonable surrogate; if elevated, consider full ABG.
When ABG is useful preoperatively:
  • Thoracic surgery and lung resection planning
  • New or worsened respiratory symptoms requiring workup
  • Suspected OHS or severe COPD (to guide postoperative ventilation planning)

5. Serum Albumin

What it measures: Nutritional status and systemic inflammatory state; normal ≥3.5 g/dL (≥35 g/L).
Role in PPC prediction: Low albumin is a consistently identified independent risk factor for PPCs across multiple models.
  • Albumin <3.5 g/dL: OR 2.53 for pulmonary complications (Miller's Anesthesia 10e)
  • Included as a risk factor in the ACP 2006 guidelines and Arozullah respiratory failure index
  • Hypoalbuminemia reflects poor nutritional reserve, impaired respiratory muscle strength, and reduced immune defense against pneumonia
Recommendation: Obtain in patients undergoing major abdominal, thoracic, or vascular surgery, especially elderly or malnourished patients.

6. Blood Urea Nitrogen (BUN)

What it measures: Renal function and indirect marker of catabolism/dehydration.
Role in PPC prediction:
  • Elevated BUN >7.5 mmol/L (>21 mg/dL): OR 4.81 for pulmonary complications (Miller's Anesthesia 10e)
  • Included in some PPC risk models as a marker of end-organ dysfunction
  • Additive value above clinical assessment is uncertain (Murray & Nadel's)

7. Hemoglobin / Complete Blood Count (CBC)

What it measures: Anemia, baseline hematologic status.
Role in PPC prediction:
  • Hemoglobin ≤10 g/dL is one of the 7 variables in the ARISCAT score (11 risk points; OR 3.0 for PPCs)
  • Anemia impairs oxygen-carrying capacity and reduces physiologic reserve, predisposing to hypoxemia after surgery
  • Preoperative WBC and neutrophil ratio are emerging ML model predictors in thoracoscopic surgery populations
Recommendation: Obtain CBC in all moderate-to-high-risk surgical patients; hemoglobin is both a predictor and an optimizable variable.

8. Serum Bicarbonate (HCO3-)

A less discussed but practical test: elevated HCO3- in patients with suspected or known OSA suggests chronic CO2 retention and possible OHS. The Society of Anesthesia and Sleep Medicine (SASM) recommends delaying nonurgent surgery in such patients for further workup, as perioperative complication risk is substantially higher (Murray & Nadel's).

9. Lung Ultrasound (LUS)

Emerging role: Point-of-care preoperative lung ultrasound can detect occult pleural effusions, interstitial syndrome, consolidation, and reduced diaphragmatic excursion that may not be apparent clinically or on CXR. The Lung Ultrasound Score (LUS) as a perioperative PPC predictor is an active research area (Vetrugno et al., 2026, European Journal of Anaesthesiology [PMID 41340139]) though its additive value over clinical risk scores remains under investigation.

10. Ventilation-Perfusion (V/Q) Scan and Quantitative CT

For lung resection candidates only:
  • Quantitative CT volumetry can calculate predicted postoperative lung function (ppoFEV1, ppoDLCO) based on regional lung contribution
  • V/Q scintigraphy (SPECT): Measures fractional contribution of each lung segment; used when CT is not available or when regional assessment is needed
  • Both are superior to simple spirometric thresholds for estimating functional reserve after resection

Summary: When to Use Which Test

TestRoutine All SurgeryUpper Abdo/ThoracicLung ResectionCOPD/AsthmaOSA Suspected
Pulse oximetryYESYESYESYESYES
Spirometry (FEV1/FVC)NoConsiderMandatoryIf uncontrolledNo
DLCONoNoMandatoryRarelyNo
Chest X-rayNo (if asymptomatic)YES (age ≥50)YESIf uncontrolledNo
ABGNoSelectedYESSevere/CO2 retainerIf HCO3- elevated
Serum albuminNoYESYESNoNo
BUNNoConsiderConsiderNoNo
Hemoglobin/CBCModerate-high riskYESYESYESNo
Serum HCO3-Screen for OSANoNoNoYES
Lung ultrasoundNoEmergingEmergingNoNo
Quantitative CT/V/QNoNoLung resectionNoNo

Bottom line from the evidence: The best-performing preoperative tests for PPC prediction are pulse oximetry (SpO2) and serum hemoglobin - both incorporated into ARISCAT. Spirometry adds value primarily for thoracic surgery and suspected COPD. ABG, albumin, and BUN contribute to risk models but rarely change management when clinical assessment is thorough. The general principle (Harrison's 22e; Murray & Nadel's) is: preoperative labs and imaging should not be ordered routinely but targeted to patient risk and surgical procedure.
This is a shared conversation. Sign in to Orris to start your own chat.